Anzeige
Mehr »
Dienstag, 10.02.2026 - Börsentäglich über 12.000 News
Breaking News: Pacifica meldet neue hochgradige Entdeckung und genau deshalb kann der Markt das nicht ignorieren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A116WJ | ISIN: US74039D1019 | Ticker-Symbol:
Branche
Konsumgüter
Aktienmarkt
Sonstige
1-Jahres-Chart
CELLEV8 NUTRITION INC Chart 1 Jahr
5-Tage-Chart
CELLEV8 NUTRITION INC 5-Tage-Chart
ACCESS Newswire
282 Leser
Artikel bewerten:
(1)

Cellev8 Nutrition Inc.: Cellev8 Receives Official Name Change by FINRA

Preferred Commerce takes next steps with FINRA for Corporate Name Change to Cellev8 Nutrition Inc. (CELV)

WELLINGTON, FL / ACCESS Newswire / January 27, 2026 / Preferred Commerce announced today that it has received final approval from the Financial Industry Regulatory Authority (FINRA) to change its corporate name to Cellev8 Nutrition Inc. (CELV), marking a major milestone in the company's path toward becoming a category-defining brand in cellular wellness and next-generation nutrition.

"This is very important to our path forward," said Michael Ferraro, CEO and Founder of Cellev8 Nutrition Inc. "Cellev8 is much more than a one-off product - the company has its sights set on being the next household brand in wellness and nutrition. Our products are not just vitamins or basic antioxidants; each product begins with a foundation of SOD (Superoxide Dismutase) designed to support the body's most powerful natural defense system."

Breaking Through an 80-Year Scientific Barrier

For more than 80 years, scientists and physicians around the world have been studying SOD for its unique role as the body's most potent primary antioxidant. However, safe and effective oral delivery of SOD has been a major scientific challenge due to degradation in the digestive tract.

Cellev8's proprietary VitaShield delivery approach is designed to help protect SOD and complementary nutrients through digestion, representing one of the first commercially viable strategies for practical, consumer-ready use of SOD in wellness applications.

Targeting Large and Growing Market Categories

Cellev8 is positioned at the convergence of several high-growth consumer markets, including cellular health, recovery, performance, cognition, sleep, and metabolic wellness. The U.S. dietary supplements market exceeds $60 billion annually, while the global category is estimated at over $180 billion and growing across sports performance, healthy aging, and everyday wellness.

Cellev8 intends to unlock new consumer adoption by bringing proven cellular-level science into convenient daily formats," added Ferraro.

World-Class Scientific Network

Cellev8 has assembled a world-class network of scientists, physicians, nutritionists, dietitians, and performance specialists who understand the clinical relevance of SOD and its role in cellular defense. These experts have worked with elite athletes, Olympic teams, and professional sports organizations worldwide, and have seen first-hand the impact SOD-supported wellness can have on recovery, resilience, and performance.

Cellev8's Product Portfolio

Prime Recovery - everyday recovery
ReDrive - performance energy
SlimCell - metabolic & weight management
Sleep Shield - rest & recovery
Focus & Memory - cognitive clarity
Cellev8 Kids - growth & eye support

Each product is developed with SOD, with differentiating formulas to effectively target the body's daily battles whether it be support because of natural depletion of SOD or recovery from exercise, supporting inflammatory response, athletic training, weight loss and weight management, better sleep, cognitive functions, ocular support, and many more in the queue.

Elite Sports & Consumer Adoption

Cellev8 products have been used by thousands of consumers and more than 60 professional sports teams across the NBA, NFL, NHL, MLB, MLS, Olympic programs, and other elite training environments.

"Our mission is to help athletes, pro or consumer athletes, recover faster, feel better natural energy and well being, said Ferraro. We love to hear what we have heard from thousands already, "I feel great every day now!"

About Cellev8 Nutrition Inc. (CELV)

Cellev8 Nutrition Inc. is a cellular-wellness company developing next-generation supplements centered around SOD (Superoxide Dismutase), antioxidants, and advanced nutrient protection systems. Cellev8 offers formulated solutions for recovery, performance, sleep, cognition, weight management, and whole-body resilience.

Company Contact:

Cellev8 Nutrition Inc. (CELV)
3361 Fairland Farms Rd., Unit 3
Wellington, FL 33414
Contact: Michael Ferraro, CEO
Email: Mike@Cellev8.com
Phone: (561) 578-0000

Regulatory & Disclosure Statements
FDA Disclosure:

These statements have not been evaluated by the Food and Drug Administration. Cellev8 products are not intended to diagnose, treat, cure, or prevent any disease.

SEC/FINRA/Capital Markets Disclosure:

The FINRA approval referenced herein relates solely to the corporate name change and does not constitute investment advice, an offer, or solicitation to buy or sell securities.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of U.S. federal securities laws.

SOURCE: Cellev8 Nutrition Inc.



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cellev8-receives-official-name-change-by-finra-1130919

© 2026 ACCESS Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.